Dhaka, April 6 -- Renata PLC has begun exporting medicines to the US market, becoming the sixth pharmaceutical manufacturer from Bangladesh to directly ship products to the world's largest market.
In its first shipment, Renata dispatched 12.8 million Metoprolol Tartrate tablets for the US market today, according to a press release of the company. The drugs were produced at its Rajendrapur facility.
Metoprolol Tartrate is used for treating hypertension, angina, heart failure, and other cardiovascular conditions.
Before this, five Bangladeshi pharmaceutical manufacturers - Eskayef Pharmaceuticals Ltd, Square Pharmaceuticals Ltd, Beximco Pharmaceuticals Ltd, Incepta Pharmaceuticals Ltd, and ACI Limited - began exporting medicines to the US ...